Blog Archives
Top 5 News Stories 11/17 – 11/23
1) Shire, Boston Children’s enter research agreement – Mass High Tech – 11/20/2012
Irish drug giant Shire plc (Nasdaq: SHPG) will pay Boston Children’s Hospital an undisclosed amount under a three-year research agreement intended to find new candidates to treat a range of rare pediatric diseases. Link
2) Biotech Industry Skyrockets in 2012 as FDA New Drug Approval Rate Increases - Marketwire – 11/20/2012
The Biotech Industry has skyrocketed in 2012 as an increase in the number of new drug approvals has boosted investor optimism within the industry. The iShares Nasdaq Biotechnology Index Fund (IBB) and the SPDR S&P Biotech ETF (XBI) have both gained over 25 percent year-to-date. Link
3) Bristol-Pfizer anticlot drug gets key EU approval - Boston.com – 11/20/2012
European regulators have approved a crucial new anticlotting drug, Eliquis, for preventing strokes and dangerous clots in the circulatory system, the drug’s makers said Tuesday. Eliquis was approved for use in the 27 European Union countries in patients who have an irregular heartbeat called atrial fibrillation and are at risk for strokes or dangerous clots called systemic embolisms. Link Read the rest of this entry
Top 5 News Stories 6/1-6/8
1. Vertex, Epizyme, Rib-X named best places to work Mass High Tech – 6/4/12
The Scientist magazine’s yearly Best Places to Work awards have often shone a light on New England companies and this year is no exception. Little Cambridge, Mass-based personalized medicine company Epizyme, with 45 employees, nabbed the number 2 spot nationwide, while its neighbor, the much larger Vertex Pharmaceuticals (Nasdaq: VRTX), with 2047 workers, scored the number 5 spot. Link
2. Boston Biotech Industry Takes Center Stage at the 2012 BIO International Convention Market Watch – 6/5/12
The 2012 BIO International Convention will return to Boston, Mass. for the global event for biotechnology, which will take place June 18-21, 2012 at the Boston Convention and Exhibition Center. Link
3. WPI gets $3M NSF grant for biofabrication program Mass High Tech – 6/6/12
Worcester Polytechnic Institute (WPI) has received a five-year, $3 million award from the National Science Foundation (NSF) to launch a graduate program in biofabrication geared toward turning students into innovators. Link
New Members
Atreaon, Inc., is a privately held biopharmaceutical company developing a novel engineered protein called Atsttrin, for the treatment of inflammatory diseases such as rheumatoid arthritis. Atreaon recently completed a $20 million Series A financing to support the pre-clinical development of Atsttrin. Link
KeraFAST, Inc, provides “Extraordinary Products…from Extraordinary Scientists” as the next generation of research tools for life science laboratories worldwide. KeraFAST offers an incomparable assortment of unique bioreagents, rare materials, biologicals, solutions, labware and services through its e-commerce catalog. Link
PerkinElmer is taking action to harness the power of insights and transform them into knowledge to deliver innovative, differentiated solutions for our customers. From critical therapeutic and disease research and prenatal screening, to environmental testing and industrial monitoring, we are actively engaged in improving health and advancing quality and longevity of life all around the world. Link
Sirius Analytical offers both instrumentation and CRO services for measurement of pKa, logP/logD, Solubility and Dissolution including detailed customized studies of Solubility, Supersaturation and Dissolution with real-time pH control in formulation excipients and biorelevant media. Link
